BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15999202)

  • 1. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
    Kaffy J; Pontikis R; Florent JC; Monneret C
    Org Biomol Chem; 2005 Jul; 3(14):2657-60. PubMed ID: 15999202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regio- and stereospecific synthesis of mono-beta-d-glucuronic acid derivatives of combretastatin A-1.
    Tanpure RP; Strecker TE; Chaplin DJ; Siim BG; Trawick ML; Pinney KG
    J Nat Prod; 2010 Jun; 73(6):1093-101. PubMed ID: 20496923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ; Sriram M; Strecker TE; Tidmore JK; Jelinek CJ; Kumar GD; Hadimani MB; Pettit GR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5146-9. PubMed ID: 18710804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents.
    Wu M; Sun Q; Yang C; Chen D; Ding J; Chen Y; Lin L; Xie Y
    Bioorg Med Chem Lett; 2007 Feb; 17(4):869-73. PubMed ID: 17174089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
    Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
    J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).
    Pettit GR; Minardi MD; Rosenberg HJ; Hamel E; Bibby MC; Martin SW; Jung MK; Pettit RK; Cuthbertson TJ; Chapuis JC
    J Nat Prod; 2005 Oct; 68(10):1450-8. PubMed ID: 16252907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumor activity of benzils related to combretastatin A-4.
    Mousset C; Giraud A; Provot O; Hamze A; Bignon J; Liu JM; Thoret S; Dubois J; Brion JD; Alami M
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3266-71. PubMed ID: 18477509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation.
    Kaffy J; Pontikis R; Carrez D; Croisy A; Monneret C; Florent JC
    Bioorg Med Chem; 2006 Jun; 14(12):4067-77. PubMed ID: 16510288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins.
    Bailly C; Bal C; Barbier P; Combes S; Finet JP; Hildebrand MP; Peyrot V; Wattez N
    J Med Chem; 2003 Dec; 46(25):5437-44. PubMed ID: 14640552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of cis-locked vinylogous combretastatin-A4 analogues: derivatives with a cyclopropyl-vinyl or a cyclopropyl-amide bridge.
    Ty N; Kaffy J; Arrault A; Thoret S; Pontikis R; Dubois J; Morin-Allory L; Florent JC
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1318-22. PubMed ID: 19211248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
    Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
    J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
    Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cytotoxic evaluation of N-(4-methoxy-1H-benzo[d]imidazol-7-yl)-arylsulfonamide and N-aryl-(4-methoxy-1H-benzo[d]imidazol)-7-sulfonamide analogs of combretastatin A-4.
    Zhou J; Zhang Y; Cui YW; Li ZM; Song HR; Dong JH; Chen XG; Xu BL
    J Asian Nat Prod Res; 2011 Apr; 13(4):330-40. PubMed ID: 21462036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
    Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA
    J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity.
    Simoni D; Romagnoli R; Baruchello R; Rondanin R; Grisolia G; Eleopra M; Rizzi M; Tolomeo M; Giannini G; Alloatti D; Castorina M; Marcellini M; Pisano C
    J Med Chem; 2008 Oct; 51(19):6211-5. PubMed ID: 18783207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation.
    Borrel C; Thoret S; Cachet X; Guénard D; Tillequin F; Koch M; Michel S
    Bioorg Med Chem; 2005 Jun; 13(11):3853-64. PubMed ID: 15863010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Phenyl-N'-(2-chloroethyl)urea analogues of combretastatin A-4: Is the N-phenyl-N'-(2-chloroethyl)urea pharmacophore mimicking the trimethoxy phenyl moiety?
    Fortin S; Moreau E; Lacroix J; Teulade JC; Patenaude A; C-Gaudreault R
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2000-4. PubMed ID: 17291753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineoplastic agents 442. Synthesis and biological activities of dioxostatin.
    Pettit GR; Lippert JW; Boyd MR; Verdier-Pinard P; Hamel E
    Anticancer Drug Des; 2000 Oct; 15(5):361-71. PubMed ID: 11354312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
    Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of constrained heterocyclic analogues of combretastatin A4.
    Arthuis M; Pontikis R; Chabot GG; Seguin J; Quentin L; Bourg S; Morin-Allory L; Florent JC
    ChemMedChem; 2011 Sep; 6(9):1693-705. PubMed ID: 21732536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.